MobiHealth News July 6, 2022
More than 80% of cancer patients and survivors who responded to the survey were willing to use the majority of remote interventions, like oral medications delivered to the home, electronic informed consent and wearables.
Remote technology and decentralized clinical trials could increase the likelihood of patient participation, according to a study published in JAMA Network Open.
Researchers surveyed 1,183 cancer patients and survivors about their interest in clinical trials and their willingness to use remote interventions. Only 18% had participated in a cancer clinical trial. Meanwhile, 77% reported they would join a trial if it were at least as easy to access as their regular care in terms of distance and frequency of visits, and 47% said they would...
Today's Sponsors
Today's Sponsor